cas 950382-89-5|| where to buy 2-{1-[3-(4-chlorophenyl)-2,1-benzoxazol-5-yl]-5-methyl-1H-1,2,3-triazole-4-carbonyl}-1,2,3,4-tetrahydroisoquinoline

製品名:2-{1-[3-(4-chlorophenyl)-2,1-benzoxazol-5-yl]-5-methyl-1H-1,2,3-triazole-4-carbonyl}-1,2,3,4-tetrahydroisoquinoline

IUPAC Name:2-{1-[3-(4-chlorophenyl)-2,1-benzoxazol-5-yl]-5-methyl-1H-1,2,3-triazole-4-carbonyl}-1,2,3,4-tetrahydroisoquinoline

包装単位	有効在庫	価格（USD）	数量

研究開発用専用.

問い合わせフォーム

化学物質名

CAS番号

数量*

要求仕様*
（アッセイ %、材料グレード等）

お名前*

連絡先Eメールアドレス*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 950382-89-5 regularly via the above email.

追記事項

Verification code*

refresh

: CAS番号:950382-89-5; 分子式:C26H20ClN5O2; 融点:-; SMILESコード:CC1=C(N=NN1C1=CC2=C(ON=C2C=C1)C1=CC=C(Cl)C=C1)C(=O)N1CCC2=C(C1)C=CC=C2; 密度:

: Triazoles; Triazole refers to a heterocyclic compound with the molecular formula C2H3N3, which has a five-membered ring consisting of two carbon atoms and three nitrogen atoms. Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease already affect many people around the world, and these numbers are increasing rapidly. Treatment for these disorders is often aimed at relieving symptoms and has no cure. Research on new molecules is underway, and heterocyclic compounds have important pharmacological implications. Triazoles and tetrazoles are emerging as new molecules in this field.

: Benzoisoxazoles; 1,2-Benzoisoxazole is an aromatic organic compound with the molecular formula C7H5NO containing a benzene-fused isoxazole ring structure. The compound itself has no general application; however, functionalized benzoxazoles and benzoisoxazoles have a variety of uses, including therapeutic drugs such as some antipsychotics (including risperidone, paliperidone, cape ketone and iloperidone) and the anticonvulsant azolamide.

: Tetrahydroisoquinolines; Tetrahydroisoquinoline is an organic compound with the chemical formula C9H11N. It is classified as a secondary amine, obtained from isoquinoline by hydrogenation. The tetrahydroisoquinoline moiety forms the backbone of several natural, synthetic and semi-synthetic drugs approved for the treatment of cancer, pain, gout and various neurodegenerative diseases.